Pseudomyxoma Peritonei: Understanding Your Pathology Report

Section Editor: David Driman MBChB FRCPC
November 17, 2026


Print this article

Pseudomyxoma peritonei (PMP) is a condition in which mucin, a thick jelly-like substance, builds up inside the abdomen. It happens when a mucin-producing tumor spreads across the lining of the abdomen, called the peritoneum. In most people, the tumor starts in the appendix. When the mucin contains tumor cells, PMP is treated as a form of cancer, even if those cells look low grade.

This article explains what PMP is, where it starts, and how pathologists classify it. It also explains the grade, stage, and other terms you may see in a pathology report from the appendix, the omentum, or the lining of the abdomen.

What is pseudomyxoma peritonei?

Pseudomyxoma peritonei is the name for the pattern of disease seen when mucin and tumor cells spread inside the abdomen. The mucin collects in places where fluid naturally pools, such as under the diaphragm, in the pelvis, and over the omentum, a fatty apron of tissue hanging in the abdomen.

Because the term describes what the surgeon and radiologist see rather than a single tumor type, your pathology report will usually give a more specific diagnosis, it will say whether the mucin contains tumor cells and, if so, what those cells look like, as described in the classification section below.

Where does pseudomyxoma peritonei start?

Most cases of pseudomyxoma peritonei start from a mucin-producing tumor of the appendix. The tumor fills the appendix with mucin until the wall weakens or bursts, and tumor cells then escape into the abdomen. The tumors most often responsible are:

Less often, PMP starts from a mucinous tumor of the ovary, colon, or pancreas. In women with PMP and an ovarian mass, the appendix is still the usual starting point, and the ovarian mass is spread from the appendix.

Who gets pseudomyxoma peritonei?

Pseudomyxoma peritonei is rare, affecting about 1 to 3 people per million each year, and the cause of the underlying appendiceal tumor is not known. Most low-grade cases have mutations in both the KRAS and GNAS genes. GNAS changes increase mucin production, and TP53 mutations are more common in high-grade cases.

What are the symptoms of pseudomyxoma peritonei?

Pseudomyxoma peritonei usually grows slowly so that symptoms can build up over months or years, and the most common symptom is gradual abdominal swelling. Other symptoms include:

  • A new hernia. Mucin can push into a weak spot at the belly button or groin.
  • Feeling full quickly. Mucin presses on the stomach and bowel.
  • Symptoms like appendicitis. Pain in the lower right abdomen can occur when the appendix tumor bursts.
  • An ovarian mass in women. Spread to the ovary is sometimes the first sign.

Some people have no symptoms, and the disease is found on a scan or during surgery for another reason.

How is the diagnosis made?

Pseudomyxoma peritonei is usually suspected on a CT scan, which shows mucin filling the abdomen and coating the organs. Blood tests for tumor markers, such as CEA, CA19-9, and CA-125, are often elevated. A pathologist confirms the diagnosis by examining tissue under the microscope.

That tissue may come from a biopsy of the peritoneum or omentum, from the appendix, or from a larger operation. The pathologist examines the mucin carefully for tumor cells, which can be sparse and scattered. Because many pieces of tissue are often needed, these reports can take longer than a routine biopsy report.

The pathologist may use immunohistochemistry to confirm where the tumor started. Tumor cells from the appendix usually make CK20 and CDX2, proteins found in bowel lining cells. Cells from an ovarian tumor usually show a different pattern, and the appendix itself is examined in full when it is removed.

How is pseudomyxoma peritonei classified?

Pathologists classify pseudomyxoma peritonei by examining the mucin and tumor cells in the abdomen. The system most widely used was published in 2016 by the Peritoneal Surface Oncology Group International (PSOGI). It has four categories:

  • Acellular mucin. Mucin is present in the abdomen, but no tumor cells are found. This is called acellular mucin and has the best outlook.
  • Low-grade mucinous carcinoma peritonei. Tumor cells are present but appear only mildly abnormal, and there are few. This category is the most common. An older name is disseminated peritoneal adenomucinosis (DPAM).
  • High-grade mucinous carcinoma peritonei. The tumor cells look clearly abnormal, are more numerous, or invade tissue. An older name is peritoneal mucinous carcinomatosis (PMCA).
  • High-grade mucinous carcinoma peritonei with signet ring cells. Some tumor cells are signet ring cells, which are cells filled with mucin that push the nucleus to one side. This category has the least favorable outlook.

Your report may use these names, the older names, or simply “low grade” and “high grade.” It may also describe how many tumor cells are in the mucin.

Histologic grade

The grade of pseudomyxoma peritonei describes how abnormal the tumor cells in the abdomen look. Grade is the most important pathology finding in PMP because it predicts disease behavior and guides treatment decisions. The College of American Pathologists (CAP) appendix protocol, version 5.1.0.0 (2022), grades PMP to match the PSOGI categories:

  • Grade 1 (G1). Acellular mucin, or low-grade tumor cells in low numbers with no invasion of tissue. This matches acellular mucin and low-grade mucinous carcinoma peritonei.
  • Grade 2 (G2). High-grade tumor cells without signet ring cells. This matches high-grade mucinous carcinoma peritonei.
  • Grade 3 (G3). Tumor with signet ring cells.

When the disease in the abdomen has a different grade from the tumor in the appendix, use the grade of the disease in the abdomen for staging.

Pathologic stage

Pseudomyxoma peritonei that starts in the appendix is staged with the American Joint Committee on Cancer (AJCC) system for appendix carcinomas, Version 9 (2023). Because the disease has already spread beyond the appendix into the abdomen, it is always stage IV. Our article on TNM staging explains how we assign stage.

  • M1a, stage IVA. Only acellular mucin is found in the abdomen.
  • M1b with grade 1, stage IVA. Low-grade tumor cells are found in the abdomen.
  • M1b with grade 2 or 3, stage IVB. High-grade tumor cells, with or without signet ring cells, are found in the abdomen.
  • M1c, stage IVC. The disease has spread beyond the lining of the abdomen, for example to the liver or lungs. This is uncommon.

Stage IV in PMP does not carry the same meaning as stage IV in most cancers. Many people with stage IVA disease live for many years after treatment.

Peritoneal cancer index and completeness of cytoreduction

Two scores describe how much pseudomyxoma peritonei is present and how much was removed. The surgeon records them, so you will usually find them in operative or oncology notes rather than the pathology report.

  • Peritoneal cancer index (PCI). The surgeon divides the abdomen into 13 regions and scores the amount of disease in each one—the total ranges from 0 to 39. A higher score means more widespread disease.
  • Completeness of cytoreduction (CC) score. This describes how much visible disease remains after surgery. CC-0 means no visible disease remains, while CC-2 and CC-3 mean larger amounts remain.

Complete or near-complete removal of all visible disease is one of the strongest predictors of a good outcome.

What is the prognosis?

The prognosis for pseudomyxoma peritonei depends mainly on the grade and on whether all visible disease can be removed. In an international registry of 2,298 people treated at specialist centers, 74% were alive after 5 years and 63% after 10 years. In other words, about 37% of people in that registry were not alive at 10 years.

Outcomes differ clearly by category. In one large Italian series, about 90% of people with acellular mucin were alive after 10 years. The figure was about 63% for low-grade disease and about 40% for high-grade disease. Signet ring cell disease had the poorest outlook.

Features associated with a less favorable outcome include:

  • High-grade or signet ring cells. These tumors behave more like typical cancers.
  • Incomplete removal. Visible disease left after surgery is linked to a shorter survival.
  • A high peritoneal cancer index. More widespread disease is harder to remove completely.
  • Spread outside the abdomen (M1c). This is uncommon but harder to treat.

PMP can return even after complete removal, sometimes years later, so long-term follow-up is important.

What happens after the diagnosis?

Pseudomyxoma peritonei is rare, so treatment is concentrated in specialist centers that perform many of these operations. The treatment plan depends on the grade, the amount of disease, and your general health.

  • Cytoreductive surgery and HIPEC. The main treatment for most people. The surgeon removes all visible tumor and mucin, which can involve removing the omentum, parts of the bowel, and the lining of the abdomen. Heat-activated chemotherapy, called HIPEC, is then washed through the abdomen during the same operation. In the international registry, 2% of people died from the treatment, and 24% had a major complication.
  • Removal of the ovaries. In women, the ovaries are a common site of spread, and the team may discuss removing them during surgery.
  • Chemotherapy. Chemotherapy given into a vein may be considered for high-grade disease or when complete surgery is not possible.
  • Observation. When only a small amount of acellular mucin is found, close follow-up with scans may be recommended instead of major surgery.
  • Follow-up. Regular CT or MRI scans and tumor marker blood tests are used for many years to watch for the disease returning.

Questions to ask your doctor

  • Did the pathologist find tumor cells in the mucin, or was it acellular?
  • Is my PMP low-grade or high-grade, and were any signet ring cells found?
  • Where did my PMP start, and what did the appendix show?
  • What is my stage, and what does stage IVA or IVB mean in my case?
  • What was my peritoneal cancer index?
  • Am I a candidate for cytoreductive surgery and HIPEC?
  • Should I be referred to a specialist center for peritoneal disease?
  • Was all visible disease removed, and what was my completeness of cytoreduction score?
  • Should my ovaries be removed?
  • Will I need chemotherapy?
  • Which scans and blood tests will be used to follow me, and for how long?
  • What symptoms should prompt me to call between visits?

Related articles on MyPathologyReport.com

A+ A A-
Was this article helpful?